The short answer
Retevmo (Selpercatinib) is a targeted therapy called a kinase inhibitor. It blocks a changed RET protein that drives some lung and thyroid cancers, slowing their growth. It is used for some lung and thyroid cancers with a RET gene change, and for other solid tumors with a RET gene fusion, in adults and in children from 2 years old. It is taken as capsules or tablets by mouth each day. Like all cancer medicines it can cause side effects; this page explains the common ones and the warning signs to report. It is educational only and not a substitute for your care team's advice.
Retevmo is the brand name; its generic name is selpercatinib.
It is a targeted therapy called a kinase inhibitor — it blocks a changed RET protein that drives some lung and thyroid cancers, slowing their growth.
It is used for some lung and thyroid cancers with a RET gene change, and for other solid tumors with a RET gene fusion, down to age 2.
It is usually given as capsules or tablets taken by mouth each day.
Choose how you want to understand this
The full explanation.
One target: a RET gene switched on by mistake
RET is a gene that helps nerves and other tissues develop. In some cancers it goes wrong in one of two ways.
Sometimes a piece of RET breaks off and joins a different gene. That is called a fusion, and the joined gene makes a protein that is stuck in the on position. Sometimes a single letter of RET changes instead, which is called a mutation and has a similar effect.
Selpercatinib was built to fit that RET protein and block it. Retevmo is the brand name; selpercatinib is the generic name.
Lung, thyroid, and any solid tumor with a RET fusion
The label covers four groups.
- Adults with non-small cell lung cancer that has spread or is locally advanced and has a RET fusion.
- Adults and children from 2 years old with advanced or spread medullary thyroid cancer carrying a RET mutation, who need drug treatment.
- Adults and children from 2 years old with advanced or spread thyroid cancer carrying a RET fusion, who need drug treatment and whose cancer no longer responds to radioactive iodine.
- Adults and children from 2 years old with any other solid tumor carrying a RET fusion, once it has grown despite earlier treatment or there is no good alternative.
That fourth group is unusual. It does not name an organ at all. The RET fusion itself is the ticket.
An approved test comes first
You cannot tell from a scan whether a cancer has a RET change. It takes a laboratory test on the tumor tissue, or in some cases on blood, and the label requires an FDA-approved one.
RET changes are uncommon, so most people tested will not have one. A negative result is the ordinary result. It closes off this drug, not your treatment options.
Blood pressure is the effect to expect
High blood pressure occurred in 43% of people taking selpercatinib. In 20% it was severe.
That makes it the side effect most likely to change your daily routine. Your team will want your blood pressure controlled before you start, and checked after the first week, then regularly. Many people are given a blood pressure medicine alongside.
A home monitor is worth asking about. Bring the readings to appointments.
Liver tests and a heart tracing
Liver enzymes rise in more than half of people on this drug. Most of the time there are no symptoms at all, which is exactly why blood is tested on a schedule rather than when you feel unwell.
Selpercatinib can also stretch the heart's electrical cycle, seen on an ECG as a long QT interval. Expect tracings before and during treatment, and tell your team about every other medicine you take, because some add to the same effect.
Serious bleeding has occurred, and some cases were fatal. Coughing up blood, blood in stool or urine, or a bad headache with confusion needs urgent care.
Tell your team before any planned surgery
This drug can slow wound healing. The label says to stop it at least 7 days before planned surgery, and not to restart it for at least 2 weeks afterwards, and until the wound has healed.
That includes dental surgery and other procedures that may not feel like a big deal. Mention selpercatinib to anyone booking one.
Allergic reactions, and a warning for thyroid cancer
Some people develop a reaction with fever, rash and aching joints, alongside falling platelets or rising liver enzymes. It shows up around two weeks in. Report a rash rather than assuming it is a virus, and if a temperature comes with it, phone at once rather than waiting.
In medullary thyroid cancer with a large amount of disease, breaking cancer cells down quickly can overwhelm the kidneys. This is tumor lysis syndrome. Extra fluids and blood tests in the first weeks are how it is prevented.
When to get help sooner
- Call 911 or go to an emergency department if you cough up blood, pass blood in your stool or urine, or get a sudden severe headache with confusion. Go too if you faint or your heart pounds and will not settle.
- Call 911 or go to an emergency department if your lips or tongue swell, your throat tightens, or you struggle to breathe after a dose.
- Ring your cancer team at once, day or night, if your temperature reaches 100.4°F (38°C) or higher. While you are on this treatment a fever counts as a medical emergency, whether or not chills come with it and whether or not anyone has told you your white cells are low. Selpercatinib can lower those cells, and you cannot tell from how you feel. If nobody answers within minutes, go to an emergency department and say straight away that you are on cancer treatment.
- Go to an emergency department the same day if diarrhoea is frequent and will not stop, you cannot keep fluids down, or you feel faint standing up. Losing that much fluid can injure the kidneys, and drips may be needed.
- Call your care team the same day if a rash and aching joints appear, especially around two weeks in. Do not put that down to a virus. If a temperature comes with them, use the emergency bullet above and call at once instead. Ring the same day as well for a home blood pressure reading well above the number your team set for you, for a headache with blurred vision, or if you pass much less urine than usual.
- Call your care team within a day or two if your readings drift up over several days, if looser stools are becoming a daily pattern, or if you have a procedure booked, including dental work, so the 7-day stop before surgery can be arranged.
Sources
Words to know
Tap any term to see what it means.

Common questions
What is Retevmo?
Retevmo (Selpercatinib) is a targeted therapy called a kinase inhibitor. It blocks a changed RET protein that drives some lung and thyroid cancers, slowing their growth. It is used for some lung and thyroid cancers with a RET gene change, and for other solid tumors with a RET gene fusion, in adults and in children from 2 years old.
How is Retevmo given?
It is usually given as capsules or tablets taken by mouth each day. It is taken as pills or capsules by mouth, often once or twice a day at home. Take it exactly as prescribed and ask your team before stopping or changing it. The exact schedule is set by your care team.
What are the common side effects of Retevmo?
Commonly reported side effects include dry mouth, diarrhea, high blood pressure, tiredness, and changes in liver blood tests. Not everyone gets them, and many can be managed. Tell your care team about anything new or worsening.
Does Retevmo cure cancer?
That depends on the person, the cancer type, and its stage. For some people a medicine like this can control cancer for a long time or be part of a curative plan; for others the goal is to slow the cancer or ease symptoms. Your care team can explain the goal in your situation.
Questions to ask your doctor
Being prepared helps you get the most out of your appointments. Save or print these questions.
Tap a question to save it to your list (kept on this device).
Speak With Trained Specialists & Human Navigators
Cancer Explained provides educational guidance, but does not replace trained specialists, social workers, or your medical team.
Talk to a trained cancer information specialist
Free, confidential assistance from NCI Cancer Information Service via phone, chat, or email.
Contact your oncology team
Locate after-hours contact numbers, portal messages, or urgent triage phone lines.
Find a patient navigator
Get one-on-one help with appointments, logistics, translation, and care coordination.
Find a genetic counselor
Discuss inherited mutation risk, family history, and genetic testing options.
Find an oncology social worker
Access emotional counseling, family support groups, and mental health resources.
Find a financial navigator
Locate copay assistance foundations, grant programs, and lodging/travel support.
Find a clinical-trial specialist
Search matching studies and speak with NCI trial information specialists.
Get urgent help
Immediate emergency guidance for fever (>100.4°F during chemo), severe pain, or shortness of breath.
Help Us Improve This Guide
Did this explanation answer your question and help you determine your next step?
Know someone who needs this?
Plenty of people are looking for something like this and do not know where to start. If this would help a friend or someone you love, send it on — we have written an opening line so you do not have to stare at an empty message. You can change every word of it.
Your message is written and sent in your own email or messaging app — we never see who you send it to, and nothing is added to any list.
Knowledge Check
0 of 2 answered
This self-assessment checks understanding of educational content only. It is not medical advice.
Plain-language explanation of the published sources cited on this page. AI-assisted, source-checked, not clinician-reviewed.
Sources last checked: 2026-08-13 what this meansLast updated: 2026-08-18Next planned review: 2027-01-14
How this page was created
Cancer Explained does not originate medical claims. Every page restates guidance already published by the National Cancer Institute, the CDC, the USPSTF and the FDA, in plain language, with the source cited so you can check the original yourself. AI does the translating and organizing; automated checks test claims, citations, clarity and safety before anything publishes. We do not employ clinicians and do not intend to — our work is translation and navigation, not clinical judgment. Nothing here is personal medical advice, and no page can account for your particular situation.
Editorial status — Editorial review complete. This page completed Cancer Explained's editorial checks (sources, safety, plain language, duplication). It has not been reviewed by a physician or other healthcare professional.
General education — varies by person. Answers genuinely differ between people. This page explains what commonly varies and points you to your care team for your situation.
Human medical review: not completed. Pages here are not signed off by a clinician before they publish. That is not an oversight we are quietly working around: we restate published guidance and cite it, so the authority belongs to the source rather than to us, and every page names where its claims come from — you can verify us instead of trusting us. Where a volunteer clinician has reviewed a page, their name and credentials appear on it; where no name appears, no clinician has checked it. We are glad to have reviewers and are recruiting them, and we do not hold pages back waiting for one. Use this site to understand your situation and to ask better questions of the people treating you.
How this page was created
Cancer Explained does not originate medical claims. Every page restates guidance already published by the National Cancer Institute, the CDC, the USPSTF and the FDA, in plain language, with the source cited so you can check the original yourself. AI does the translating and organizing; automated checks test claims, citations, clarity and safety before anything publishes. We do not employ clinicians and do not intend to — our work is translation and navigation, not clinical judgment. Nothing here is personal medical advice, and no page can account for your particular situation.
Editorial status: Editorial review complete — This page completed Cancer Explained's editorial checks (sources, safety, plain language, duplication). It has not been reviewed by a physician or other healthcare professional.
Human medical review: not completed. Pages here are not signed off by a clinician before they publish. That is not an oversight we are quietly working around: we restate published guidance and cite it, so the authority belongs to the source rather than to us, and every page names where its claims come from — you can verify us instead of trusting us. Where a volunteer clinician has reviewed a page, their name and credentials appear on it; where no name appears, no clinician has checked it. We are glad to have reviewers and are recruiting them, and we do not hold pages back waiting for one. Use this site to understand your situation and to ask better questions of the people treating you.
Read more about our editorial process, our use of AI, and our corrections policy.
Spotted a problem? Report an error — a factual mistake, broken or outdated source, confusing wording, or anything that seems unsafe. Please do not include names, medical record numbers, dates of birth, addresses, or other identifying medical information in your report.
After using this page, do you understand what to do next?
Anonymous — we only record the answer, never who gave it.
Related articles
Still have questions?
Educational answers, plain language
Free to print and share
